However, from ecological point of view, the increasing use of UV filters constitutes a potential risk wastewater, at tens to several hundreds ng/L in treated wastewater, up to a hundred ng/L in lake water and at ng/g levels in solid matrices and in biota (Vione et al., 2013 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Methods

Chemicals and Media
The IUPAC name of Oxybenzone (CAS n. 131-57-7) is 2-Hydroxy-4-methoxybenzophenone. nuclei, respectively, and N is the total number of cells scored.
Blood Sample Collection and Lymphocyte cultures
Cytokinesis-Block Micronucleus Assay
Chromosomal Aberrations Assay
Microscope analysis was performed at 1000X magnification on a light microscope (Dialux 20, Leica, Germany). Althogh the Organization for Economic Co-operation and Development (OECD) guidelines call for 100 metaphases to be scored for each dose (OECD, 2015), in order to obtain results more significant and suitable for statistical analysis, it is the normal practice in our laboratory to score 200 metaphases per subject per dose. Thus, in the present work, for each subject and BP-3 concentration, 200 well-spread first-division complete metaphases (for a total of 1000 metaphases for each dose) were analysed for the following categories of CAs: gaps, chromatid breaks (B'), chromosome breaks (B"), dicentrics (Dic), rings (R), tri-or tetra-radials (TR), acentric fragments (AF), rearrangements (Re) and numerical aberrations. Cells containing one of more types of CAs were scored as "aberrant cell" (Ab.C).
With regard to the opportunity to include gaps in the statistical analyses, the discussion is open.
Although some authors considered gaps as the appropriate indicator of genotoxic potential of chemicals (Savage, 2004) , the molecular mechanism of BP-3 to induce achromatic lesion/gaps is yet to be revealed. Thus, in our statistical analyses we decided to exclude gaps. The criteria for distinguishing chromatide breaks from gaps were the acentric piece displaced with respect to the chromosome axis and the size of the discontinuity, which exceeded the width of the chromatide. A 
Statistical analysis
Comparison of mean values of the percentage of cells with MNs, CBPI and CAs between exposition levels and their controls was assessed by the non-parametric Mann-Whytney test.
Statistical calculations were carried out using the SPSS software package program (version 23.0, Inc., Chicago, IL, USA). All P values were two tailed, and P values of 5% or less were considered statistically significant for all tests carried out. (Table 3) .
Results
Effect of BP-3 on CAs formation
No significant differences were found between the DMSO solvent-control and the negative control (P = 0.142), whereas the cultures treated with the known mutagen MMC showed a significant increase of CAs and Ab.C with respect to all BP-3 tested concentrations (P < 0.05), including the negative and solvent control cultures (P = 0.008 and P = 0.009, respectively).
Effect of BP-3 on MNs formation
To verify both the aneugenic and clastogenic effects of BP-3, the MN test was assessed in parallel with CAs test (Table 2) . Similarly to what we already observed with the CAs assay, our results indicated that BP-3 significantly increased the MNs formation at all concentrations tested, including both 0.10 µg/mL, that represents the TDI established by EU for this substance, and 0.0125 µg/mL that represents an eighth of this limit value. Also in this case, a dose-effect was observed since the regresson analysis revealed a significant (P<0.001) correlation between the BP-3 concentrations and the frequencies of MNs and Cells with MNs ( Table 3 ).
The (Tables 2 and 3 ).
Discussion
BP-3 is widely used as sunscreen for protection of human skin and hair from damage by ultraviolet radiation. It has been found in many cosmetic products and its production and use has been rapidly increasing over the past decade. As consequence of this increased production, BP-3 was found to have a wide presence in aquatic environments, affecting the water quality and, consequently, the Notably, for BP-3 we observed a clastogenic effect also at the lower concentrations of 0.025 and 0.0125 µg/mL, whereas for the BP-A, another endocrine disruptor compound with a very similar molecular weight to that of BP-3, we failed to found it (Santovito et al., 2017). This more acute effect of BP-3 with respect of BP-A has been observed, by our group, also in in vivo experiments conducted using the marine polychaete Ophryotrocha diadema. In this case, we found an increased mortality and a lower production of eggs among polychaete treated with the same concentrations of Although recent studies on BP-3 have demonstrated its cytotoxicity properties (Balázs et al., 2016) and its capacity to activate apoptosis (Wnuk et al., 2017) , in the present study we did not observed a significant reduction of the CBPI, indicating that BP-3 does not seem to produce effects on the proliferation/mitotic index when its concentration is equal or less than 0.20 µg/mL (Tables 2 and 3 ).
Finally, it should be also emphasized that the observed cytogenetic damage cannot be ascribed 
Conclusion
The results herein reported demonstrate, for the first time in literature, the clastogenic and aneugenic effects of BP-3 on cultured human lymphocytes, by increasing CAs and MNs frequencies also at lower concentrations with respect to those established by European Union.
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